Imipramine Pamoate Contraindications in Adolescent Depression

Introduction to Contraindications

The American Academy of Child and Adolescent Psychiatry recommends that imipramine pamoate and all tricyclic antidepressants should not be prescribed to adolescents with depression due to lack of proven efficacy, high lethality in overdose, and availability of safer, more effective alternatives 1, 2, 3

Tricyclic antidepressants have not been proven effective in treating depression in children or adolescents in controlled trials 1
The American Academy of Child and Adolescent Psychiatry explicitly states that tricyclics carry greater lethal potential and should be avoided in this population 3
Cardiac arrhythmia risk exists even at therapeutic doses of tricyclics, with one reported death of a child on combined desipramine and dextroamphetamine 4

The American Academy of Pediatrics recommends fluoxetine as a first-line treatment for adolescent depression, with the most robust evidence for safety and efficacy in adolescents aged 12 years and older 2, 3
Escitalopram is FDA-approved for adolescents aged 12-17 years with depression 3
Combination treatment with fluoxetine plus cognitive-behavioral therapy (CBT) provides superior outcomes compared to either treatment alone 2

Imipramine is indicated for childhood enuresis in children aged 6 and older at doses of 25-50 mg at bedtime, but should only be used as third-line therapy after enuresis alarms and desmopressin have failed 5, 6

If a clinician encounters an adolescent already on imipramine for depression, immediate assessment within 1 week is necessary to evaluate depressive symptoms, suicide risk, adverse effects, adherence, and environmental stressors 3
ECG monitoring before treatment and periodically thereafter is necessary due to cardiac conduction risks 5, 6
Secure medication storage is necessary to prevent access by the patient or siblings, given fatal overdose potential 6
A plan to transition to an SSRI, preferably fluoxetine, with gradual taper of imipramine is necessary to avoid withdrawal symptoms 3